Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
|
0.590 |
GeneticVariation
|
disease |
BEFREE |
In the patient diagnosed with aCML in bone marrow study, two CSF3R mutations, (T618I and Y779*) a SETBP1 mutation (G870S) and an U2AF1 mutation (Q157P), were identified by high-coverage next-generation sequencing.
|
31692115 |
2020 |
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
|
0.590 |
GeneticVariation
|
disease |
BEFREE |
Blast content of the bone marrow revealed an inverse correlation with the mutation status of SETBP1 in aCML and TET2 in CMML, respectively.
|
30635983 |
2019 |
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
|
0.590 |
GeneticVariation
|
disease |
BEFREE |
SETBP1 variants occur as somatic mutations in several hematological malignancies such as atypical chronic myeloid leukemia and as de novo germline mutations in the Schinzel-Giedion syndrome.
|
29875417 |
2018 |
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
|
0.590 |
GeneticVariation
|
disease |
BEFREE |
Despite the recent identification of recurrent SETBP1 mutations in atypical chronic myeloid leukemia (aCML), a complete description of the somatic lesions responsible for the onset of this disorder is still lacking.
|
25343957 |
2015 |
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
|
0.590 |
GeneticVariation
|
disease |
BEFREE |
Recurrent somatic SET-binding protein 1 (SETBP1) and splicing pathway gene mutations have recently been found in atypical chronic myeloid leukemia and other hematologic malignancies.
|
25553291 |
2015 |
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
|
0.590 |
GeneticVariation
|
disease |
BEFREE |
SETBP1 mutations may be associated with an adverse prognosis, so their detection would help in the diagnosis of aCML and the determination of a patient's prognosis.
|
26017341 |
2015 |
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
|
0.590 |
Biomarker
|
disease |
CTD_human |
In summary, mutated SETBP1 represents a newly discovered oncogene present in aCML and closely related diseases.
|
23222956 |
2013 |
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
|
0.590 |
GeneticVariation
|
disease |
BEFREE |
Here we report whole-exome sequencing of individuals with various myeloid malignancies and identify recurrent somatic mutations in SETBP1, consistent with a recent report on atypical chronic myeloid leukemia (aCML).
|
23832012 |
2013 |
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
|
0.590 |
GeneticVariation
|
disease |
BEFREE |
In particular, there was a high frequency of SETBP1 mutation in aCML (19/60; 31.7%) and MDS/MPN unclassifiable (MDS/MPN, U; 20/240; 9.3%).
|
23628959 |
2013 |
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
|
0.590 |
Biomarker
|
disease |
BEFREE |
In summary, mutated SETBP1 represents a newly discovered oncogene present in aCML and closely related diseases.
|
23222956 |
2013 |
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
|
0.590 |
CausalMutation
|
disease |
CGI |
|
|
|